Skip to main content
SpringerLink
Log in

Exome sequencing cost effective in children with autism?

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2016 Canadian dollars

Reference

  • Yuen T, et al. Cost-effectiveness of Genome and Exome Sequencing in Children Diagnosed with Autism Spectrum Disorder. Applied Health Economics and Health Policy : 12 Apr 2018. Available from: URL: http://doi.org/10.1007/s40258-018-0390-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Exome sequencing cost effective in children with autism?. PharmacoEcon Outcomes News 802, 13 (2018). https://doi.org/10.1007/s40274-018-4904-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4904-4

Search

Navigation